Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, biosimilars, human and veterinary IMPs as well as generics.
We support pharmaceutical and biotechnology companies worldwide across the full drug development lifecycle from research and development through clinical trials to regulatory submission and market release.
Our main service areas include:
1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+36 beds.
2) Bioanalytical Testing: GLP/GCP solutions for BE/BA/PK preclinical & clinical studies, small molecules, biologics and biosimilars. PD studies upon request.
3) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities and HAPIs.
4) Biologics Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars, Cell-based assay.
5) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies.
6) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins.
Quinta was founded and headquartered in Prague, Czech Republic in 1997 and has been successfully inspected by FDA more than 12 times.
We are part of the Conscio group with headquarter in Munich (Germany) and laboratories in Czechia, Austria, Slovakia and Germany.
Company Details
- Employees
- 180
- Founded
- -
- Address
- Prazska 1486/18c, Praha 10,10200,czech Republic
- Phone
- 420 242 454 311
- qu****@****inta.cz
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- quinta.cz
- Keywords
- Bioanalysis of small molecules, BA/BE studies and Phase 1, Pharmacokinetic and toxicokinetic studies, Analytical methods development, validation and transfer, Extractables and leachables, Impurities R&D, Nitrosamine screening and quantification, Formulation design, Bioanalysis of large molecules, GLP and GMP analyses of biopharmaceuticals, GMP quality control, release testing, stability studies, ICH and on-going stability testing, Analytics of Biosimilars, Characterizations of Biopharmaceuticals, Analytics of dry powder inhalers, Microbiological testing, In vitro release and permeation testing, Routine batch testing for release, Bacterial endotoxins, Clinical trials.
- HQ
- Praha 10
Quinta-Analytica Questions
Quinta-Analytica's helpline number is 420 242 454 311
Quinta-Analytica's website is quinta.cz
Quinta-Analytica's LinkedIn profile is https://www.linkedin.com/company/quinta-analytica
Quinta-Analytica has
180 employees.
View email and phone details for 180
employees at Quinta-Analytica.
Quinta-Analytica's industry is
Pharmaceutical Manufacturing
Quinta-Analytica's top competitors are
Synthon Česká Republika,
Gen-Plus Gmbh & Co. Kg,
Farmak, A.s.,
Cayman Pharma S.r.o.,
Oncomed Manufacturing A.s.,
Conscio Group,
Bioveta, A. S.,
Pro.med.cs,
Zentiva,
Nextpv Services.
Quinta-Analytica's support email address is quinta@quinta.cz
Quinta-Analytica's categories are Pharmaceutical Manufacturing
Quinta-Analytica's founding year is 1997
